These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29019159)

  • 41. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
    Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
    Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model.
    Ren X; Zhang T; Gong X; Hu G; Ding W; Wang X
    Exp Neurol; 2013 Oct; 248():148-56. PubMed ID: 23764500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP.
    Filichia E; Hoffer B; Qi X; Luo Y
    Sci Rep; 2016 Sep; 6():32656. PubMed ID: 27619562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
    Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
    Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats.
    Lima LAR; Lopes MJP; Costa RO; Lima FAV; Neves KRT; Calou IBF; Andrade GM; Viana GSB
    J Neuroinflammation; 2018 Aug; 15(1):249. PubMed ID: 30170624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitochondria: A Therapeutic Target for Parkinson's Disease?
    Luo Y; Hoffer A; Hoffer B; Qi X
    Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deep brain stimulation of the subthalamic nucleus in the 6-hydroxydopamine rat model of Parkinson's disease: effects on sensorimotor gating.
    Lindemann C; Krauss JK; Schwabe K
    Behav Brain Res; 2012 Apr; 230(1):243-50. PubMed ID: 22330948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic Defects in Mitochondrial Dynamics in
    Hartman JH; Gonzalez-Hunt C; Hall SM; Ryde IT; Caldwell KA; Caldwell GA; Meyer JN
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
    Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
    Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective effect of Nrf2-ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson's disease model.
    Masaki Y; Izumi Y; Matsumura A; Akaike A; Kume T
    Eur J Pharmacol; 2017 Mar; 798():26-34. PubMed ID: 28167258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
    Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
    Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective effects of β- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson's disease.
    Shan C; Gong YL; Zhuang QQ; Hou YF; Wang SM; Zhu Q; Huang GR; Tao B; Sun LH; Zhao HY; Li ST; Liu JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109670. PubMed ID: 31220519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
    Kääriäinen TM; Piltonen M; Ossola B; Kekki H; Lehtonen S; Nenonen T; Lecklin A; Raasmaja A; Männistö PT
    Brain Res; 2008 Apr; 1203():149-59. PubMed ID: 18329008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
    Frau L; Morelli M; Simola N
    Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease.
    Solesio ME; Prime TA; Logan A; Murphy MP; Del Mar Arroyo-Jimenez M; Jordán J; Galindo MF
    Biochim Biophys Acta; 2013 Jan; 1832(1):174-82. PubMed ID: 22846607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.